Your session is about to expire
← Back to Search
Probiotic for Attention Deficit Disorder
Study Summary
This trial is investigating whether probiotics can help people perform better on a task after experiencing stress.
- Stress
- Attention Deficit Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who has the opportunity to take part in this medical research?
"This research is seeking to enlist 36 participants, aged 19-35, who have experienced stress. Eligibility criteria necessitates that individuals must be of both genders and able to give informed consent. Moreover, potential subjects should have spent at least 5 hours per week for the prior year playing action video games such as first- and third-person shooters or roleplaying titles; willingness to continue this level of gaming during the trial period is also required. Furthermore, applicants must commit to maintaining their current diet regimen throughout the study and abstaining from probiotic supplements and fiber products like Metamucil or Benefiber while participating in it. Additionally,"
Are there currently any opportunities for participants to join this experiment?
"According to the information on clinicaltrials.gov, this particular medical trial is not currently open for participant recruitment. Initially posted in October 1st 2022 and last updated on September 15th 2022, unfortunately there are no available spots at present; however, 144 other studies remain actively recruiting patients."
Is the age limit of 85+ years imposed on participants for this research endeavor?
"As per the study's requirements, prospective participants must possess a minimum age of 19 and an upper boundary of 35."
Does the FDA certify Probiotic as a safe and effective product?
"Probiotic's safety has been partially validated, granting it a score of 2. However, no clinical data is currently available to assess its efficacy in this Phase 2 trial."
Share this study with friends
Copy Link
Messenger